Skip to main content
. 2011 Feb 8;3(2):8. doi: 10.1186/gm222

Figure 1.

Figure 1

Prominent host and viral genetic factors that influence the outcome of IFN-based therapy for HCV. The best-documented host genetic factors that favor viral clearance and HCV factors that promote viral survival during therapy are indicated. HLA, human leukocyte antigen; ITPA, inosine triphosphatase; SNP, single-nucleotide polymorphism.